Assessment Of COVID-19 Virus Infection Among Patients With Atherosclerosis


  • Salah Hassan Yousif Hawler Medical University, College of Medicine, Medicine department, at Erbil/ Iraq
  • Ahmed Abdulqader Abdulsalam Rizgary Teaching Hospital-Erbil general directory, Ministry of Health- Erbil-Iraq
  • Sevan Hassan Bakir Erbil Polytechnic University/Erbil Medical Technical Institute -Erbil- Medical Laboratory Technology Department Erbil-Iraq
  • Shwan Othman Amen Surgical specialty hospital - cardiac center, Erbil general directory, Ministry of Health- Erbil-Iraq



Keywords: COVID-19: coronavirus disease caused by the SARS-CoV-2 virus., COPD: chronic obstructive pulmonary disease.


Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and 3000000 patient’s worldwide COVID-19 is caused by severe acute respiratory syndrome coronavirus which invades cells through the angiotensin-converting enzyme receptors among patients with COVID-19 there is a high prevalence of cardiovascular disease.


Patients and Methods :The data were collected from patients which had been recovered from covid -19 virus and they have to progress in the disease to have atherosclerosis and some of the patients had a sign and symptoms of COPD. A total of 125 patients were taken for this study were taken for this study including both sex male and female with different age groups all of them admitted to specialized surgical-cardiac center hospital in Erbil City in Iraq. All of them suspected to have atherosclerosis so they will be detected by angiograph in catheterization laboratory in the hospital.

Conclusion: this study demonstrated that COVID-19 virus are also significant risk factors for coronary artery disease and patients who recovered from COVID-19 have had been suffered more from that increasing the severity of disease on them.


- Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time [published online February 19, 2020]. Lancet Infect Dis. doi: 10.1016/S1473-3099(20)30120-

- Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686–689. doi: 10.1136/thorax.58.8.686 Crossref. PubMed.

- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease Control and prevention. J Am Med Assoc 2020.

- ] The world health organization coronavirus disease 2019 (COVID-19) situation report e61. Available at:-, coronaviruse/situation-reports/20200321-sitrep-61-covid-19.pdf? sfvrsn¼f201f85c_2. [Accessed 22 March 2020].

- Biasucci, L.M.; Leo, M.; De Maria, G.L. Local and systemic mechanisms of plaque rupture. Angiology 2008, 59, 73S–76S. [CrossRef].

- Corrales-Medina, V.F.; Madjid, M.; Musher, D.M. Role of acute infection in triggering acute coronary syndromes. Lancet Infect. Dis. 2010, 10, 83–92. [CrossRef].

- infections and acute coronary syndromes. J. Infect. 2013, 66, 1–17. [CrossRef] 31. Belkaid, Y.; Rouse, B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6, 353–360. [CrossRef] [PubMed]

- Qin, C.; Zhou, L.; Hu, Z.; Zhang, S.; Yang, S.; Tao, Y.; Xie, C.; Ma, K.; Shang, K.; Wang, W.; et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020, 71, 762–768. [CrossRef] [PubMed.



How to Cite

Yousif, S., Abdulsalam, A., Hassan, S., & Amen, S. . (2023). Assessment Of COVID-19 Virus Infection Among Patients With Atherosclerosis. Pharmacy and Applied Health Sciences, 2(1), 2–8.



Research Article